BGI Genomics Co., Ltd.
SHZ: 300676.SZ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Yujue Wang
- Employees
- 3,702
- Headquarters
- Shenzhen, China
- IPO year
- 2017
- Market cap
- CN¥18.0B
- Website
- https://www.bgi.com
Loading 300676…
Loading profile data…Frequently asked questions about 300676
What does BGI Genomics Co., Ltd. (300676.SZ) do?
BGI Genomics Co., Ltd. provides sequencing services and a portfolio of genetic tests for medical institutions, research institutions, and other public and private partners in China and internationally. The company offers DNA, RNA, and customized sequencing services; and non-invasive prenatal testing, reproductive health screening, newborn geneti...
Where does 300676.SZ trade?
BGI Genomics Co., Ltd. (300676.SZ) trades on the Shenzhen Stock Exchange.
What sector is 300676.SZ in?
BGI Genomics Co., Ltd. (300676.SZ) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of BGI Genomics Co., Ltd.?
Yujue Wang is the chief executive officer of BGI Genomics Co., Ltd. (300676.SZ).
Where is BGI Genomics Co., Ltd. headquartered?
BGI Genomics Co., Ltd. is headquartered in China.
Does 300676.SZ pay a dividend?
Yes — BGI Genomics Co., Ltd. (300676.SZ) paid a trailing twelve-month dividend of CNY 0.10 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 300676.SZ go public?
BGI Genomics Co., Ltd. (300676.SZ) completed its initial public offering in 2017.